Back
Palisade Bio, Inc. 10K Form
Sell
45
PALI
Palisade Bio, Inc.
Last Price:
$1.80
Seasonality Move:
-1.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PALI News And Ratings
See the #1 stock for the next 7 days that we like better than PALI
PALI Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.35 |
| Price / Book: | 83.67 |
Profitability
| EPS (TTM): | -4.21910 |
|---|---|
| Net Income (TTM): | $-11.2M |
| Gross Margin: | $-3K |
| Return on Equity: | -222.18% |
| Return on Assets: | -133.5% |
Palisade Bio, Inc. Earnings Forecast
Key Palisade Bio, Inc. Financial Ratios
-
Per Share Earnings over the last 20 years have been positive in 15 years.
Palisade Bio, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PALI |
| Website: | palisadebio.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PALI Technical Analysis vs Fundamental Analysis
Sell
45
Palisade Bio, Inc. (PALI)
is a Sell
Is Palisade Bio, Inc. a Buy or a Sell?
-
Palisade Bio, Inc. stock is rated a SellThe current Palisade Bio, Inc. [PALI] share price is $1.80. The Score for PALI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.